415 related articles for article (PubMed ID: 17224156)
41. The immunology and pathogenesis of malaria during pregnancy.
Beeson JG; Duffy PE
Curr Top Microbiol Immunol; 2005; 297():187-227. PubMed ID: 16265906
[TBL] [Abstract][Full Text] [Related]
42. Targets of protective antibodies to malaria during pregnancy.
Beeson JG; Rogerson SJ; Elliott SR; Duffy MF
J Infect Dis; 2005 Nov; 192(9):1647-50. PubMed ID: 16206081
[No Abstract] [Full Text] [Related]
43. Placental malaria is associated with cell-mediated inflammatory responses with selective absence of natural killer cells.
Ordi J; Menendez C; Ismail MR; Ventura PJ; Palacín A; Kahigwa E; Ferrer B; Cardesa A; Alonso PL
J Infect Dis; 2001 Apr; 183(7):1100-7. PubMed ID: 11237836
[TBL] [Abstract][Full Text] [Related]
44. Genetic analysis of ID1-DBL2X predicts its validity as a vaccine candidate in Colombia and supports at least two independently introduced Plasmodium falciparum populations in the region.
Rajwani J; Klinger CM; Arango E; Arroyo MI; Sabbagh A; Maestre A; Dacks JB; Gnidehou S; Yanow SK
Infect Genet Evol; 2017 Nov; 55():175-185. PubMed ID: 28893687
[TBL] [Abstract][Full Text] [Related]
45. [Malaria--immunity gaps and how to stop them].
Hviid L
Ugeskr Laeger; 2000 Nov; 162(46):6224-6. PubMed ID: 11107975
[No Abstract] [Full Text] [Related]
46. Cytoadhesion of Plasmodium falciparum ring-stage-infected erythrocytes.
Pouvelle B; Buffet PA; Lépolard C; Scherf A; Gysin J
Nat Med; 2000 Nov; 6(11):1264-8. PubMed ID: 11062539
[TBL] [Abstract][Full Text] [Related]
47. Does malaria suffer from lack of memory?
Struik SS; Riley EM
Immunol Rev; 2004 Oct; 201():268-90. PubMed ID: 15361247
[TBL] [Abstract][Full Text] [Related]
48. Infected erythrocyte binding to hyaluronic acid and malaria in pregnant women.
Smith JD; Miller LH
J Infect Dis; 2004 Jan; 189(2):165-8. PubMed ID: 14722879
[No Abstract] [Full Text] [Related]
49. Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?
Sutherland CJ
Mol Biochem Parasitol; 2009 Aug; 166(2):93-8. PubMed ID: 19450726
[TBL] [Abstract][Full Text] [Related]
50. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains.
Dahlbäck M; Jørgensen LM; Nielsen MA; Clausen TM; Ditlev SB; Resende M; Pinto VV; Arnot DE; Theander TG; Salanti A
J Biol Chem; 2011 May; 286(18):15908-17. PubMed ID: 21398524
[TBL] [Abstract][Full Text] [Related]
51. The distinct proteome of placental malaria parasites.
Fried M; Hixson KK; Anderson L; Ogata Y; Mutabingwa TK; Duffy PE
Mol Biochem Parasitol; 2007 Sep; 155(1):57-65. PubMed ID: 17618698
[TBL] [Abstract][Full Text] [Related]
52. Development of vaccines to prevent malaria in pregnant women: WHO MALVAC meeting report.
Menéndez C; Moorthy VS; Reed Z; Bardají A; Alonso P; Brown GV
Expert Rev Vaccines; 2011 Sep; 10(9):1271-80. PubMed ID: 21919617
[TBL] [Abstract][Full Text] [Related]
53. Malaria, primigravidae, and antibodies: knowledge gained and future perspectives.
Ataíde R; Mayor A; Rogerson SJ
Trends Parasitol; 2014 Feb; 30(2):85-94. PubMed ID: 24388420
[TBL] [Abstract][Full Text] [Related]
54. Adhesion specificities of Plasmodium falciparum-infected erythrocytes involved in the pathogenesis of pregnancy-associated malaria.
Hviid L
Am J Pathol; 2007 Jun; 170(6):1817-9. PubMed ID: 17525250
[No Abstract] [Full Text] [Related]
55. High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women.
Magistrado PA; Minja D; Doritchamou J; Ndam NT; John D; Schmiegelow C; Massougbodji A; Dahlbäck M; Ditlev SB; Pinto VV; Resende M; Lusingu J; Theander TG; Salanti A; Nielsen MA
Vaccine; 2011 Jan; 29(3):437-43. PubMed ID: 21075162
[TBL] [Abstract][Full Text] [Related]
56. Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon.
Suguitan AL; Cadigan TJ; Nguyen TA; Zhou A; Leke RJ; Metenou S; Thuita L; Megnekou R; Fogako J; Leke RG; Taylor DW
Am J Trop Med Hyg; 2003 Dec; 69(6):574-81. PubMed ID: 14740871
[TBL] [Abstract][Full Text] [Related]
57. Detection and clinical manifestation of placental malaria in southern Ghana.
Mockenhaupt FP; Bedu-Addo G; von Gaertner C; Boyé R; Fricke K; Hannibal I; Karakaya F; Schaller M; Ulmen U; Acquah PA; Dietz E; Eggelte TA; Bienzle U
Malar J; 2006 Dec; 5():119. PubMed ID: 17166266
[TBL] [Abstract][Full Text] [Related]
58. Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria.
Suguitan AL; Leke RG; Fouda G; Zhou A; Thuita L; Metenou S; Fogako J; Megnekou R; Taylor DW
J Infect Dis; 2003 Oct; 188(7):1074-82. PubMed ID: 14513430
[TBL] [Abstract][Full Text] [Related]
59. Towards a vaccine against pregnancy-associated malaria.
Tuikue Ndam N; Deloron P
Parasite; 2008 Sep; 15(3):515-21. PubMed ID: 18814733
[TBL] [Abstract][Full Text] [Related]
60. Molecular interactions in the placenta during malaria infection.
Mens PF; Bojtor EC; Schallig HD
Eur J Obstet Gynecol Reprod Biol; 2010 Oct; 152(2):126-32. PubMed ID: 20933151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
